These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 8603833

  • 1. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity.
    Stone J, Chan-Ling T, Pe'er J, Itin A, Gnessin H, Keshet E.
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):290-9. PubMed ID: 8603833
    [Abstract] [Full Text] [Related]

  • 2. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
    McLeod DS, Taomoto M, Cao J, Zhu Z, Witte L, Lutty GA.
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
    [Abstract] [Full Text] [Related]

  • 3. Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia.
    Ozaki NK, Beharry KD, Nishihara KC, Akmal Y, Ang JG, Sheikh R, Modanlou HD.
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1546-57. PubMed ID: 11980873
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
    Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW.
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice.
    Brooks SE, Gu X, Samuel S, Marcus DM, Bartoli M, Huang PL, Caldwell RB.
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):222-8. PubMed ID: 11133872
    [Abstract] [Full Text] [Related]

  • 8. Colocalization of neuropilin-1 and Flk-1 in retinal neovascularization in a mouse model of retinopathy.
    Ishihama H, Ohbayashi M, Kurosawa N, Kitsukawa T, Matsuura O, Miyake Y, Muramatsu T.
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1172-8. PubMed ID: 11328724
    [Abstract] [Full Text] [Related]

  • 9. Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy.
    Taomoto M, McLeod DS, Merges C, Lutty GA.
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):230-43. PubMed ID: 10634625
    [Abstract] [Full Text] [Related]

  • 10. The temporal and spatial vascular endothelial growth factor expression in retinal vasculogenesis of rat neonates.
    Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K.
    Lab Invest; 1996 Jan; 74(1):68-77. PubMed ID: 8569199
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.
    Pierce EA, Foley ED, Smith LE.
    Arch Ophthalmol; 1996 Oct; 114(10):1219-28. PubMed ID: 8859081
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity.
    Lashkari K, Hirose T, Yazdany J, McMeel JW, Kazlauskas A, Rahimi N.
    Am J Pathol; 2000 Apr; 156(4):1337-44. PubMed ID: 10751359
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
    Stitt AW, Simpson DA, Boocock C, Gardiner TA, Murphy GM, Archer DB.
    J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.
    Brafman A, Mett I, Shafir M, Gottlieb H, Damari G, Gozlan-Kelner S, Vishnevskia-Dai V, Skaliter R, Einat P, Faerman A, Feinstein E, Shoshani T.
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3796-805. PubMed ID: 15452091
    [Abstract] [Full Text] [Related]

  • 20. Clinical and histopathologic features of canine oxygen-induced proliferative retinopathy.
    McLeod DS, D'Anna SA, Lutty GA.
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1918-32. PubMed ID: 9727415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.